Thomas Charles Heineman, Chief Medical Officer: Oncolytics Biotech ONCY Buy · Filed 02/13

Trade details

Type: Insider buy
Amount: $10,069.56
Shares · price: 12,132 sh · $0.83 a share
Held after: 282,818 sh
Stock: Oncolytics Biotech ONCY
Person: Thomas Charles HeinemanChief Medical Officer
Trade date: 26/02/12
Filed: 26/02/13
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 9 insiders
Holding change: +4.5%

Oncolytics Biotech trades, last 26 weeks

What else happened in Oncolytics Biotech around then

Filed or reported within 30 days of the trade day · 01/13~03/14

Thomas Charles Heineman's recent trades

No other trades yet.